Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated BM-MNC Transplantation in Lower Limb Ischemic Ulcer
NCT01480414Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Sep 2010
- Primary completion
- Apr 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of bone marrow mononuclear cells in peripheral artery disease (PAD) and critical limb ischemia (CLI) (2 arms), sponsored by Royan Institute. Primary endpoint: Side effects at 3 months. Started Sep 2010; status: completed.
02
Drugs
bone marrow mononuclear cells
03
Conditions
peripheral artery disease (PAD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01480414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480414.